StockData
AVITA Medical, Inc. logo

AVITA Medical, Inc. (RCEL) stock

RCELNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as AVHHL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$15.77+0.55 (+3.61%)

Close on Nov 17, 2026Market cap $487.72MP/E –Yield –

AVITA Medical operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

AVITA Medical's operating cash flow for the twelve months ending Jun 30, 2026 was -$24.23M. For fiscal 2025 it was -$31.20M. The highest annual figure on record is -$12.96M in fiscal 2018.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$31.20M–
FY2024Dec 31, 2024-$48.90M–
FY2023Dec 31, 2023-$38.01M–
FY2021Jun 30, 2021-$25.90M–
FY2020Jun 30, 2020-$22.75M–
FY2019Jun 30, 2019-$19.25M–
FY2018Jun 30, 2018-$12.96M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026-$3.50M–
Q1 FY2026CQ1 2026Mar 31, 2026-$10.07M–
Q4 FY2025CQ4 2025Dec 31, 2025-$5.44M–
Q3 FY2025CQ3 2025Sep 30, 2025-$5.22M–
Q2 FY2025CQ2 2025Jun 30, 2025-$10.23M–
Q1 FY2025CQ1 2025Mar 31, 2025-$10.31M–
Q4 FY2024CQ4 2024Dec 31, 2024-$8.04M–
Q3 FY2024CQ3 2024Sep 30, 2024-$7.21M–
Q2 FY2024CQ2 2024Jun 30, 2024-$12.78M–
Q1 FY2024CQ1 2024Mar 31, 2024-$20.86M–
Q4 FY2023CQ4 2023Dec 31, 2023-$10.86M–
Q3 FY2023CQ3 2023Sep 30, 2023-$8.97M–
Q2 FY2023CQ2 2023Jun 30, 2023-$9.10M–
Q1 FY2023CQ1 2023Mar 31, 2023-$9.07M–
Q4 FY2021CQ2 2021Jun 30, 2021-$3.95M–
Q3 FY2021CQ1 2021Mar 31, 2021-$8.54M–
Q2 FY2021CQ4 2020Dec 31, 2020-$5.68M–
Q1 FY2021CQ3 2020Sep 30, 2020-$7.71M–
Q4 FY2020CQ2 2020Jun 30, 2020-$5.92M–
Q3 FY2020CQ1 2020Mar 31, 2020-$7.30M–
Q2 FY2020CQ4 2019Dec 31, 2019-$4.65M–
Q1 FY2020CQ3 2019Sep 30, 2019-$4.88M–

More AVITA Medical figures

See a number that looks wrong?